1568 related articles for article (PubMed ID: 19035499)
1. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
2. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
[TBL] [Abstract][Full Text] [Related]
3. Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease.
Camargo CZ; Sekiyama JY; Arismendi MI; Kayser C
Scand J Rheumatol; 2015; 44(1):48-55. PubMed ID: 25379977
[TBL] [Abstract][Full Text] [Related]
4. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
5. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
6. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
[TBL] [Abstract][Full Text] [Related]
7. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis.
Rajkumar VS; Sundberg C; Abraham DJ; Rubin K; Black CM
Arthritis Rheum; 1999 May; 42(5):930-41. PubMed ID: 10323448
[TBL] [Abstract][Full Text] [Related]
8. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
Kallenberg CG
Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
[TBL] [Abstract][Full Text] [Related]
9. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis.
Cutolo M; Sulli A; Pizzorni C; Accardo S
J Rheumatol; 2000 Jan; 27(1):155-60. PubMed ID: 10648032
[TBL] [Abstract][Full Text] [Related]
10. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
12. Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience.
Wildt M; Hesselstrand R; Akesson A; Scheja A
Scand J Rheumatol; 2007; 36(6):452-7. PubMed ID: 18092267
[TBL] [Abstract][Full Text] [Related]
13. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
Navon P; Yarom A; Davis E
J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
[TBL] [Abstract][Full Text] [Related]
14. Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome.
Statham BN; Rowell NR
Acta Derm Venereol; 1986; 66(2):139-43. PubMed ID: 2424237
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon.
Porciello G; Scarpato R; Ferri C; Storino F; Cagetti F; Morozzi G; Bellisai F; Migliore L; Marcolongo R; Galeazzi M
J Rheumatol; 2003 Jun; 30(6):1244-7. PubMed ID: 12784397
[TBL] [Abstract][Full Text] [Related]
16. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
17. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients.
Sulli A; Secchi ME; Pizzorni C; Cutolo M
Ann Rheum Dis; 2008 Jun; 67(6):885-7. PubMed ID: 18037628
[TBL] [Abstract][Full Text] [Related]
18. Juvenile systemic sclerosis: a follow-up study of eight patients.
Szamosi S; Maródi L; Czirják L; Ellenes Z; Szücs G
Ann N Y Acad Sci; 2005 Jun; 1051():229-34. PubMed ID: 16126963
[TBL] [Abstract][Full Text] [Related]
19. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.
Martini G; Foeldvari I; Russo R; Cuttica R; Eberhard A; Ravelli A; Lehman TJ; de Oliveira SK; Susic G; Lyskina G; Nemcova D; Sundel R; Falcini F; Girschick H; Lotito AP; Buoncompagni A; Sztajnbok F; Al-Mayouf SM; Orbàn I; Ferri C; Athreya BH; Woo P; Zulian F;
Arthritis Rheum; 2006 Dec; 54(12):3971-8. PubMed ID: 17133611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
